ASTH:NSD-Astrana Health Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 24.79

Change

0.00 (0.00)%

Market Cap

USD 1.25B

Volume

0.21M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-31 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

N/A

USD 7.86B
OPCH Option Care Health Inc

N/A

USD 5.14B
AMED Amedisys Inc

N/A

USD 3.13B
PIII P3 Health Partners Inc

N/A

USD 2.88B
SGRY Surgery Partners Inc

N/A

USD 2.84B
ACHC Acadia Healthcare Company Inc

N/A

USD 2.20B
LFST Lifestance Health Group Inc

N/A

USD 2.13B
ADUS Addus HomeCare Corporation

N/A

USD 2.04B
AVAH Aveanna Healthcare Holdings In..

N/A

USD 1.07B
HCSG Healthcare Services Group Inc

N/A

USD 1.03B

ETFs Containing ASTH

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -21.38% 34% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -21.38% 34% F 30% F
Trailing 12 Months  
Capital Gain -40.16% 33% F 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -40.16% 33% F 24% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -5.33% 43% F 31% F
Dividend Return -5.33% 43% F 29% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.17% 97% N/A 88% B+
Risk Adjusted Return -47.74% 27% F 17% F
Market Capitalization 1.25B 68% D+ 75% C

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.